For years, science has offered a simple story to explain the link between obesity and cancer: inflammation. Excess adipose tissue triggers chronic, low-grade inflammation, which in turn nudges cells toward malignancy. That story is still true – but it might not be the whole story.
New research in the journal Cancer Research points to something more fundamental: more cells, more risk.
Hyperplasia Is a Factor
As body size increases, organs like the liver, pancreas, and kidneys don’t just work harder. They actually grow larger. That’s not especially surprising. What is surprising is how they grow.
This study finds that much of that growth comes from hyperplasia – an increase in the number of cells – rather than just hypertrophy, which is cells getting bigger. In fact, for kidneys, about 60% of the growth came from adding more cells.
Why Hyperplasia Matters
Cancer starts when a cell goes rogue when it replicates. So if you have more cells, you have more “lottery tickets” for something to go wrong.
The researchers found a striking pattern: as organ size increases, cancer risk rises almost in lockstep. In fact, doubling the size of an organ roughly doubles the risk of cancer in that organ.
A New Layer of Understanding
This doesn’t replace what we already know about inflammation, hormones, or metabolism. Instead, it adds a new layer of understanding. Obesity may raise cancer risk not just by changing how cells behave, but also by increasing how many cells are even in play. The senior author of this new research, Cristian Tomasetti, tells us this insight has practical implications. For instance, it sheds light on the importance of treating and preventing the progression of obesity in childhood:
“Organs take time to grow, and it can take decades for cells to turn malignant. Childhood obesity gives organ cells a longer runway to accumulate mutations and evolve into something worse.”
It also helps explain a long-standing puzzle. Many obesity-related cancers occur in organs that have little to do with fat tissue itself. If the issue is simply “more cells at risk,” that puzzle starts to make sense.
None of this simplifies the challenge of coping with obesity or cancer. But it does clarify something important: biology is not just about what cells are doing. Sometimes, it’s about how many chances they have to do it wrong.
And that’s a perspective worth paying attention to.
Click here for the new paper in Cancer Research, here, here, and here for further perspective.
Subscribe by email to follow the accumulating evidence and observations that shape our view of health, obesity, and policy.
